Hyper-late major response after 5 years of nivolumab: role of treatment beyond progression in head and neck cancer

1. Cabezas-Camarero, S.
2. Cabrera-Martín, M.N.
3. Iglesias-Moreno, M.C.
4. Pérez-Segura, P.